Telemedicine Abortion Gains Momentum During Pandemic
— But FDA regulations on mifepristone still limit access
by Amanda D'Ambrosio, Staff Writer, MedPage Today
June 2, 2020
As access to in-person abortion clinics dwindled during the COVID-19 pandemic, providers have seen increased demand and awareness of another method of abortion care: telemedicine.
Melissa Grant, chief operating officer of carafem, a national abortion and birth control clinic, said that "there's definitely been a marked increase" in telemedicine abortions since stay-at-home orders were put in place.
Continued: https://www.medpagetoday.com/special-reports/exclusives/86841